The Research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.
The research antibodies and reagents market players are focusing on various organic and inorganic growth strategies, such as product launches, acquisition, collaboration, partnerships, agreements, and expansion to increase their market foothold. The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). The market is highly competitive, with a large number of leading market players based across developed regions such as the US and Europe. However, smaller players have emerged from niche markets to compete with global players on the basis of price and product innovation. Due to intense competition, major market players are increasingly focusing on expanding their geographic presence into the high-growth emerging markets and strengthening their market competitiveness by acquiring smaller players with the desired product quality or geographic presence.
Thermo Fisher Scientific Inc. develops and manufactures high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. The company serves customers through premier brands—Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company operates through four basic segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. It provides reagents, instruments, and consumables used in biological and medical research, discovery, the production of new drugs and vaccines, and the diagnosis of diseases through its Life Sciences Solutions segment. The Life Sciences Solutions segment includes four primary businesses, of which the biosciences business provides various reagents and antibodies for conducting biological and medical research.The company operates in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Some of its major subsidiaries are ABgene Limited (UK), Athena Diagnostics, Inc. (US), Thermo Fisher Scientific C.V. (Netherlands), Life Technologies Corporation (US), Prionics AG (Switzerland), Thermo Detection de Mexico, S.A. de C.V., Fisher Scientific Japan, Ltd., and Fisher Scientific (SEA) Pte. Ltd. (Singapore).
The Merck Group is a multinational pharmaceutical, life science, and chemical company. The company has three major business divisions—Healthcare, Life Sciences, and Performance Materials. The Life Sciences division is organized into three business areas: research solutions, process solutions, and applied solutions. The products and services offered by the Life Sciences division are used in R&D and manufacturing of biotechnological and pharmaceutical drug therapies, as well as in research and application laboratories. The research solutions segment provides consumables for filtration and sample preparation, reagents and kits for cell biology experiments, and small tools and consumables for cell analysis. This segment mainly focusses on academia and pharmaceutical research institutions. The company provides more than 300,000 products across 66 countries. Its manufacturing facilities are l ocated in Bedford (US), Jaffrey (US), Darmstadt (Germany), Molsheim (France), Beijing (China), and Bengaluru (India). Merck has a strong product and technology portfolio for research antibodies and offers innovative solutions for the life science industry. The company offers high-quality research-use products to a wide end-user base under the brand name MilliporeSigma. With a strong brand and wide geographic coverage in more than 120 countries, Merck has a well-established presence in the research antibodies market. It also plans to expand its life science offerings by investing in R&D activities and through planned business synergies. In 2019, it invested around USD 2.54 billion in R&D activities.
Browse Related Reports:
Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025